红景天在慢性阻塞性肺疾病中的应用研究进展  

Research advances in the application of Rhodiola in chronic obstructive pulmonary disease

作　　者：鲁文强[1] 冯涛[1] 李龙[1] 胡建明[1] Lu Wenqiang;Feng Tao;Li Long;Hu Jianming(Department of Respiratory and Critical Care Medicine,The First Hospital of Lanzhou University,Lanzhou 730000,China)

机构地区：[1]兰州大学第一医院呼吸与危重症医学科,兰州730000

出　　处：《保健医学研究与实践》2023年第12期151-156,共6页Health Medicine Research and Practice

基　　金：甘肃省科技计划项目重点研发计划(21YF11FA001)。

摘　　要：慢性阻塞性肺疾病(COPD)是我国极常见的呼吸系统慢病之一,患病人数接近1亿人,严重影响着人民健康及社会发展,目前治疗仍不能改变其病程。红景天是我国一种传统中药材,具有抗缺氧、抗疲乏、抗氧化等多种作用,对COPD具有一定疗效。本文就近年来红景天在COPD中的应用进展进行综述。Chronic obstructive pulmonary disease(COPD)is one of the most common respiratory chronic diseases in China,with a prevalence of nearly 100 million people,which seriously affects people's health and hinders social development.At present,the treatment cannot change the course of the disease.Rhodiola is a traditional Chinese medicinal herb with various effects such as anti-hypoxia,anti-fatigue,and antioxidant properties,which demonstrated therapeutic efficacy on COPD to some extent.This article reviews the recent advances in the application of Rhodiola in COPD.

关 键 词：慢性阻塞性肺疾病 红景天 

分 类 号：R974[医药卫生—药品]